Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
Abstract Dysregulated cholesterol metabolism is a hallmark of many cancers, including glioblastoma (GBM), but its role in disease progression is not well understood. Here, we identified cholesterol 24‐hydroxylase (CYP46A1), a brain‐specific enzyme responsible for the elimination of cholesterol throu...
Saved in:
| Main Authors: | Mingzhi Han, Shuai Wang, Ning Yang, Xu Wang, Wenbo Zhao, Halala Sdik Saed, Thomas Daubon, Bin Huang, Anjing Chen, Gang Li, Hrvoje Miletic, Frits Thorsen, Rolf Bjerkvig, Xingang Li, Jian Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-11-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201910924 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid
by: Jessica Taylor, et al.
Published: (2025-03-01) -
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
by: Serena Giannelli, et al.
Published: (2025-10-01) -
Techno‐Functional Properties of Dry and Wet Fractionated Pulse Protein Ingredients
by: Andreas Hopf, et al.
Published: (2024-12-01) -
The genetic landscape of CYP24A1 polymorphisms in cancer risk: evidence from a systematic review
by: Ssarvinna Haran Manoharan, et al.
Published: (2025-06-01) -
<i>CYP24A1</i> DNA Methylation in Colorectal Cancer as Potential Prognostic and Predictive Markers
by: Ru-Hua Zhou, et al.
Published: (2025-01-01)